Morphine and morphine precursors
Methods and materials related to the use of morphine, morphine precursors (e.g., reticuline), and inhibitors of morphine synthesis or activity to treat diseases, to reduce inflammation, or to restore normal function are provided.
1. A method for inducing nitric oxide release from cells in a mammal, said method comprising administering, to said mammal, a composition in an amount, at a frequency more frequent than once a week, and for a duration longer than one month, wherein said composition comprises one or more agents selected from the group consisting of reticuline, norlaudanosoline, and salutaridine, and wherein said amount of said composition results in less than 1 mg of said one or more agents being administered to said mammal per kg of body weight of said mammal per day.
2. The method of claim 1 , wherein said cells are immune cells.
3. The method of claim 1 , wherein said mammal is a human.
4. The method of claim 1 , wherein said composition further comprises morphine in an amount that results in less than 0.05 mg of said morphine being administered to said mammal per kg of body weight of said mammal per day.
5. The method of claim 1 , wherein said composition is in the form of a tablet.
6. The method of claim 1 , wherein said composition comprises selenium.
7. The method of claim 1 , wherein said composition comprises L-arginine.
8. The method of claim 1 , wherein said composition comprises a calcium source.
9. The method of claim 1 , wherein said amount of said composition results in less than 0.5 mg of said one or more agents being administered to said mammal per kg of body weight of said mammal per day.
10. The method of claim 1 , wherein said amount of said composition results in less than 0.05 mg of said one or more agents being administered to said mammal per kg of body weight of said mammal per day.
11. The method of claim 1 , wherein said frequency is more frequent than four times a week.
12. The method of claim 1 , wherein said frequency is between two and five times a day.
13. The method of claim 1 , wherein said frequency is once a day.
14. The method of claim 1 , wherein said duration is longer than two months.
15. The method of claim 1 , wherein said duration is longer than three months.
16. The method of claim 1 , wherein said composition comprises reticuline, norlaudanosoline, and salutaridine.